[{"id":"b06978bc-9d94-4a02-8f57-068cf0ad4b28","acronym":"","url":"https://clinicaltrials.gov/study/NCT05515185","created_at":"2022-08-25T12:57:12.824Z","updated_at":"2024-07-02T16:36:04.865Z","phase":"Phase 1","brief_title":"B7-H3 Targeting CAR-T Cells Therapy for B7-H3 Positive Solid Tumors","source_id_and_acronym":"NCT05515185","lead_sponsor":"The First People's Hospital of Lianyungang","biomarkers":" CD276","pipe":"","alterations":" ","tags":["CD276"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • KT095"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 09/09/2022","start_date":" 09/09/2022","primary_txt":" Primary completion: 09/08/2024","primary_completion_date":" 09/08/2024","study_txt":" Completion: 09/08/2024","study_completion_date":" 09/08/2024","last_update_posted":"2022-08-25"}]